Norway pharmacy online: Kjøp av viagra uten resept i Norge på nett.
Jeg har selv prøvd dette kamagra Det er billig og fungerer egentlig, jeg likte det) kjøp priligy Ikke prøvd, men du kan eksperimentere med...
Hvordan føler du deg, følsomhet etter konsumere piller?.
Viagra active ingredient patent expiration: stada group launches low-cost alternative in the market to treat erectile dysfunction
Viagra active ingredient patent expiration: STADA Group launches low-
cost alternative in the market to treat erectile dysfunction
Sildenafil generic available in pharmacies throughout Germany from Monday
Bad Vilbel, June 23, 2013 – Immediately following the patent expiration of Viagra's
active pharmaceutical ingredient, sildenafil, STADA is launching a low-cost alternative
in the market for the treatment of erectile dysfunction tomorrow, on June 24, 2013.
Delivery will be carried out in the early hours of the morning in Germany and numerous
European countries. In Germany, the Group is initially offering two so-called generics,
Sildenafil STADA and Sildenafil AL, which are significantly cheaper alternatives to the
original product. They will be distributed by the subsidiaries STADApharm and ALIUD
PHARMA. Beginning July 8, 2013, STADApharm will round out the range with the
product Silda. All of STADA's sildenafil generics are bioequivalent to Viagra and are
therefore based on the same active pharmaceutical ingredient and principle as the
“With our sales companies' product launches, we have instantly expanded the range of
therapy for men with erectile dysfunction by several alternatives with STADA's well-
known high quality”, says Hartmut Retzlaff, Chairman of the Executive Board of STADA
Arzneimittel AG. “This is an important step for effected individuals who generally see
their situation as a major burden. With our low-cost generics, we are opening up an
opportunity for these individuals to gain back the quality of life that they are
accustomed to but previously could not afford.”
The delivery of Sildenafil STADA and Sildenafil AL has been meticulously planned and
starts in the night of June 24, 2013. The first packages will reach the central STADA
warehouse in Florstadt, Germany, in the early morning hours on Monday, and will then
be delivered to pharmacies throughout Germany from there. STADA will also use its
respective sales companies to launch the sildenafil generic for the treatment of erectile
dysfunction in numerous other European markets starting on Monday. Sildenafil
generics will also be available from the STADA Group in Austria, Belgium, Denmark,
Finland, France, Ireland, Italy, Luxembourg, the Netherlands, Norway, Sweden,
Switzerland, Slovakia, Spain and the Czech Republic.
Sildenafil products sold by STADA in Germany will be offered as film-coated tablets in
dosages of 25, 50 and 100 mg. As a special feature, the 100 mg dosage of Sildenafil
AL and Silda have a cross-shaped groove so the tablets can be broken into four parts.
“We therefor offer products that can be individually tailored to the needs of the patients.
We are very happy we were able to fulfill a request communicated to us by numerous
doctors in the process”, says Retzlaff. Every Silda package will also include a case
designed to be inconspicuous so that patients can discreetly carry there medicine
everywhere. Silda is therefore the most fully equipped product.
There are four to six million men in Germany alone affected by erectile dysfunction,
which is normally somatic in origin. National and international guidelines recommend
so-called PDE5 inhibitors, such as sildenafil, which promote blood circulation in the
penis. They make an erection possible via response to treatment and sexual
stimulation. All PDE5 inhibitors are prescription drugs and are only available with
About STADA Arzneimittel AG:
STADA Arzneimittel AG is a publicly-listed company with headquarters in Bad Vilbel, Germany.
STADA consistently focuses on a multi-pillar strategy of generics and branded products (OTC)
with an increasingly international market orientation. The Group traditionally has a strong
presence in Europe and is the only independent generics producer in Germany. Worldwide,
STADA is one of the five leading companies in the generics industry and is represented in more
than 30 countries with approximately 50 subsidiaries. STADA GmbH, STADApharm, ALIUD
PHARMA and Hemopharm are German sales companies of the STADA Group. Branded
products such as Mobilat, Grippostad and Ladival are among the highest selling in their product
category in Germany. In financial year 2012, STADA achieved Group sales of Euro 1,837.5
million, adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of
Euro 367.5 million and adjusted net income of Euro 147.9 million. As of December 31, 2012,
For more information or press photos, please contact:
Proc. Aust. Soc. Anim. Prod. 2010. vol. 28 Integrated Parasite Management Reduces the Cost of Gastro-Intestinal Nematodes of Sheep on the Northern Tablelands of N.S.W. G. Kelly, L. Kahn and S. Walkden-Brown CRC for Sheep Industry Innovation, University of New England, Armidale, N.S.W., 2351. Gastrointestinal nematodes (worms) cost Australian sheep producers more than any other dise
FORM V ~ BIOLOGY ~ SCHEME OF WORK (2013 – 2014) Textbooks: Biology for IGCSE by Gareth Williams and GCSE Biology by D G Mackean. PRACTICALS Differences between sexual and asexual reproduction, and the advantages and disadvantages of each. Main methods of asexual reproduction: binary fission, budding, spore formation and vegetative reproduction (including specific examples). C